|
|
|
|
|
|
|
|
Medical News
The duo conducted a meta-analysis of genes on chromosome 20q that are found to be consistently upregulated across different human tumor types, while collecting gene transcript data of normal and tumor tissues across 11 different tumor types including brain, breast, colon, gastric, head and neck, liver, lung, ovarian, cervix, pancreas, and prostate cancers.
The 18-gene signature is revealed by the study to have robustly elevated levels across human cancers.
"We observed significant association of our signature with disease-free survival in all 18 independent data... These data indicated that our signature is broadly predictive for disease-free survival, independent of tumor type," the researchers said.
"In conclusion, our integrative multi-omics analysis of genes on chromosome 20q is paving the way to the development of additional therapeutic targets for cancers with 20q amplifications. This analysis pipeline could furthermore be potentially applied to other tumor amplicons," the researchers hoped.
Article: Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types, Snijders AM, Mao JH, Advances in Modern Oncology Research
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.